Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

From the authors:

Y. Jegal, D. S. Kim
European Respiratory Journal 2009 34: 1004-1005; DOI: 10.1183/09031936.00092909
Y. Jegal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. S. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

We thank to H. Chen and co-workers for the interest in our recent paper in the European Respiratory Journal 1, and for raising an important point with good suggestions.

We agree with their opinion, missing data is one of the biggest problems in retrospective studies and we should have discussed this in more detail. However, we still think that the missing data of our study did not markedly influence our results and conclusion 1.

Although there were many missing data in the pulmonary function tests (PFT), the clinical course of most patients were well documented. As stated in our study, 81% of patients had improved or were stable after the initial treatment 1. Although follow-up PFT was variable, as the treatment duration was different for each case, PFT was performed at the time of completion of the initial treatment in all patients, except those who died during the treatment. Death was not the main cause of missing data. Furthermore, the course of many of the missing patients was confirmed by the lung function tests performed several years later, physical check-ups at routine health examination and/or telephone interviews. The reason for loss of follow-up was not because patients were ill, but because they felt too well to visit the hospital. For example, the reason for missing PFT data in 15 patients at 12 months was due to death (n = 7), a worsened condition (n = 1), an improved or stable condition (n = 2), and PFT skipped at 12 months and then performed ≥3.5 yrs after the diagnosis (n = 1). The remaining four patients were lost to follow-up but were confirmed to be clinically stable several years later.

At 2 yrs, there was missing data for 31 patients due to death (n = 11), lost to follow-up in a worse state (n = 1), lost to follow-up in an improved or stable condition (n = 8), and the remaining 11 patients were confirmed to be stable several years later. Of these 11 patients, six did not have available PFT data and were clinically stable and five patients were confirmed to be in an improved or stable condition according to lung function tests performed 3–4 yrs following treatment.

We reanalysed our data according to the recommendation by H. Chen and co-workers. The results of “complete case analysis” and “complete case analysis including missing data” are presented in tables 1⇓ and 2⇓, respectively. In table 2⇓, we put death and cases lost to follow-up in aggravated state in the “worsened” category and patients who were lost during the follow-up but were confirmed to be clinically stable after several years in the “stable” category. Data for cases with some missing PFT data, but who performed PFT later during follow-up, was estimated and added to the appropriate categories. Patients who showed either an improvement or were in a stable condition but were lost completely were put into the “missing” category.

View this table:
  • View inline
  • View popup
Table 1—

Changes in pulmonary function over time for complete case analysis

View this table:
  • View inline
  • View popup
Table 2—

Changes in pulmonary function over time including missing data

Both tables show that lung function was improved or stable in the majority of the fibrotic nonspecific idiopathic pneumonia patients. An increasing percentage of patients showed improvement of lung function during the first year of follow-up. Although, the number of patients with improvement during the second year seems to be slightly decreased compared to those during the first year, change in forced vital capacity was persistently high in these patients. Table 2⇑ shows that the proportion of real missing patients was not so high to influence the conclusion.

In conclusion, although our data could be partially influenced by “survival bias” in the second year of the treatment and subsequently, the majority of fibrotic nonspecific idiopathic pneumonia patients improved initially and maintained an “improved or stable state” in their lung functions.

ACKNOWLEGEMENTS

We would like to thank to M.S. Lee and J.H. Lee (Ulsan University, Seoul, Republic of Korea) for the consultation regarding statistical analysis.

Statement of interest

None declared.

    • © ERS Journals Ltd

    References

    1. ↵
      Park IN, Jegal Y, Kim DS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009;33:68–76.
      OpenUrlAbstract/FREE Full Text
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 34 Issue 4 Table of Contents
    European Respiratory Journal: 34 (4)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    From the authors:
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    From the authors:
    Y. Jegal, D. S. Kim
    European Respiratory Journal Oct 2009, 34 (4) 1004-1005; DOI: 10.1183/09031936.00092909

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    From the authors:
    Y. Jegal, D. S. Kim
    European Respiratory Journal Oct 2009, 34 (4) 1004-1005; DOI: 10.1183/09031936.00092909
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • ACKNOWLEGEMENTS
      • Statement of interest
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Non-animal models for COVID-19 lung research
    • User-life of ICS/LABA inhaler devices should be considered
    • Peripheral blood eosinophil counts in European and East Asian populations
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2021 by the European Respiratory Society